《最新(2016-2016年)SCI影响因子查询(LetPub-专业SCI论文编辑进行整理)》.xls
文本预览下载声明
www.LetP SCI论文美籍专家修改润色
ISSN
Total Cites
Impact Factor
Abbreviated Journal Title (linked to journal information)
Articles
5-Year Impactor Factor
Cited Half-life
CA-CANCER J CLIN
0007-9235
ACTA CRYSTALLOGR A
0108-7673
NEW ENGL J MED
0028-4793
REV MOD PHYS
0034-6861
10.0
ANNU REV IMMUNOL
0732-0582
NAT REV MOL CELL BIO
1471-0072
NAT REV CANCER
1474-175X
NAT GENET
1061-4036
NATURE
0028-0836
NAT REV IMMUNOL
1474-1733
LANCET
0140-6736
CHEM REV
0009-2665
NAT REV GENET
1471-0056
CELL
0092-8674
SCIENCE
0036-8075
NAT BIOTECHNOL
1087-0156
NAT NANOTECHNOL
1748-3387
JAMA-J AM MED ASSOC
0098-7484
NAT MATER
1476-1122
ANNU REV BIOCHEM
0066-4154
NAT REV NEUROSCI
1471-0048
NAT REV DRUG DISCOV
1474-1776
PHYSIOL REV
0031-9333
ANNU REV PLANT BIOL
1543-5008
ANNU REV ASTRON ASTR
0066-4146
CANCER CELL
1535-6108
ANNU REV NEUROSCI
0147-006X
CHEM SOC REV
0306-0012
NAT PHOTONICS
1749-4885
CELL STEM CELL
1934-5909
NAT IMMUNOL
1529-2908
NAT MED
1078-8956
IMMUNITY
1074-7613
PROG POLYM SCI
0079-6700
ENDOCR REV
0163-769X
BEHAV BRAIN SCI
0140-525X
ACCOUNTS CHEM RES
0001-4842
ANNU REV GENET
0066-4197
LANCET NEUROL
1474-4422
ADV PHYS
0001-8732
NAT METHODS
1548-7091
NAT REV MICROBIOL
1740-1526
MAT SCI ENG R
0927-796X
PHYS REP
0370-1573
NAT CELL BIOL
1465-7392
ANNU REV PHARMACOL
0362-1642
J CLIN ONCOL
0732-183X
PHARMACOL REV
0031-6997
ANNU REV PATHOL-MECH
1553-4006
SURF SCI REP
0167-5729
NAT PHYS
1745-2473
ANNU REV PSYCHOL
0066-4308
CELL METAB
1550-4131
NAT CHEM
1755-4330
LANCET ONCOL
1470-2045
ANNU REV BIOPHYS
1936-122X
ANNU REV GENOM HUM G
1527-8204
ANN INTERN MED
0003-4819
PROG MATER SCI
0079-6425
LANCET INFECT DIS
1473-3099
ANNU REV PHYSIOL
0066-4278
NAT CHEM BIOL
1552-4450
PLOS MED
1549-1277
MOL PSYCHIATR
1359-4184
ASTRON ASTROPHYS REV
0935-4956
ECOL LETT
1461-023X
ASTROPHYS J SUPPL S
0067-0049
ANNU REV MAR SCI
1941-1405
J EXP MED
0022-1007
J NATL CANCER I
0027-8874
TRENDS ECOL EVOL
0169-5347
CIRCULATION
0009-7322
J AM COLL CARDIOL
0735-1097
MOL CELL
1097-2765
NAT NEUROSCI
1097-6256
J CLIN INVEST
显示全部